SCHEMBL15088620

SCHEMBL15088620

O=C(c1ccc(CCCN2CCCC2)cc1)c1ccc(OC2CCCCO2)cc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 1/20 0.47
HRH3 Q9Y5N1 6/20 0.46
KDM4E B2RXH2 3/20 0.46
ALDH1A1 P00352 2/20 0.46
PSMB1 P20618 1/20 0.44
PSMB5 P28074 1/20 0.44
PSMB2 P49721 1/20 0.44
ESR1 P03372 1/20 0.44
ESR2 Q92731 1/20 0.44
DRD2 P14416 1/20 0.44
BCHE P06276 4/20 0.44
ACHE P22303 4/20 0.44
KCNH2 Q12809 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
MAOB P27338 1/20 0.42
LTA4H P09960 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15067203 0.86 HRH4 (0.45) HRH4HRH3KDM4EALDH1A1PSMB1
SCHEMBL15088637 0.86 HRH4 (0.45) HRH4HRH3KDM4EALDH1A1PSMB1
SCHEMBL1186911 0.81 MEN1 (0.52) MEN1KMT2A
SCHEMBL15069831 0.80 LMNA (0.46) HRH4HRH3KDM4EALDH1A1PSMB1
SCHEMBL11767308 0.76 ELANE (0.52) HRH4ALDH1A1MEN1KMT2A
SCHEMBL17666631 0.76 KMT2A (0.41) MEN1KMT2A
SCHEMBL15088680 0.75 KMT2A (0.39) HRH4HRH3KDM4EALDH1A1PSMB1
SCHEMBL21780925 0.75 MEN1 (0.47) ALDH1A1MEN1KMT2A
SCHEMBL5725421 0.75 LSS (0.49) KDM4EALDH1A1ACHEMEN1KMT2A
SCHEMBL15067474 0.75 MEN1 (0.47) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9309211-B2 Arylalkene derivatives and use thereof as selective estrogen receptor modulators CENTAURUS BIOPHARMA CO., LTD. (CN) 2016-04-12 US disclosed
WO-2013097773-A1 NOVEL ARYLALKENE DERIVATIVES AND USE THEREOF AS SELECTIVE ESTROGEN RECEPTOR MODULATORS CENTAURUS BIOPHARMA CO., LTD. (CN) 2013-07-04 WO disclosed